MOLECULIN BIOTECH, INC.

Company

Moleculin Biotech, Inc.

Filed

February 11, 2020

Accession Number

0000902664-20-000870

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →